The Rosen Law Firm, P.A., a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of IsoRay, Inc. (NYSE:ISR) resulting from allegations that IsoRay may have issued materially misleading business information to the investing public.
On May 21, 2015, TheStreet.com published an article stating that the Company’s promotional press releases regarding the publication of a study concerning its Celsium-131 product are misleading. On this news, shares of IsoRay fell during mid-day trading $0.90 per share or 29% from its previous closing price of $3.12 per share on May 20, 2015, damaging investors.
The Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by IsoRay investors. If you purchased shares of IsoRay on or before May 21, 2015, please visit the website at http://rosenlegal.com/cases-623.html for more information. You may also contact Phillip Kim, Esq. or Kevin Chan, Esq. of The Rosen Law Firm toll free at 866-767-3653 or via email at pkim@rosenlegal.com or kchan@rosenlegal.com.
The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
View source version on businesswire.com: http://www.businesswire.com/news/home/20150521006382/en/
Contacts:
Phillip Kim, Esq.
Kevin Chan, Esq.
The
Rosen Law Firm, P.A.
275 Madison Avenue, 34th Floor
New
York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax:
(212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
kchan@rosenlegal.com
www.rosenlegal.com